[US Stock Market Movement] Recursion surged on October 5: Tempus contract renewal, AI drug discovery, and pipeline progress
Bitget异动解读2026/10/05 15:15Recursion October 5 Surge Interpretation
Keywords: Tempus contract renewal, AI drug development, pipeline progress
1. On September 15, the company signed a master agreement amendment with Tempus AI, recognizing the value of Tempus' multimodal database and the company's TxFM model. The cooperation period has been extended to 2029, involving a commitment payment of $42 million.
2. On September 20, the company presented its end-to-end AI drug development platform at the Morgan Stanley conference; REC-4881 showed a rapid and sustained reduction in gastrointestinal polyp burden in Phase II trials. The company is discussing potential registration pathways with the FDA and plans to release more data in November.
3. On April 30, the company disclosed that Recursion OS covers aspects such as biological research, molecular design, and clinical trial optimization, promoting clinical-stage drug development through a combination of internal pipelines and strategic partnerships.
(Disclaimer: This content is generated by AI technology based on publicly available information and is for reference only. It does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Boeing wins seven-year contract to accelerate PAC-3 MSE missile seeker production
Boeing (BA.US) has secured a 7-year contract to accelerate production of PAC-3 MSE missile seekers.
Spot platinum breaks through $1,720/ounce, rising 1.17% intraday
Spot platinum has just surpassed the $1,720.00/oz mark, now quoted at $1,720.20/oz, up 1.17% for the day. Nymex platinum futures main contract is now at $1,727.3/oz, up 1.61% for the day.
Crypto prices
More
